Compare QDEL & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QDEL | PGNY |
|---|---|---|
| Founded | 1979 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2022 | 2019 |
| Metric | QDEL | PGNY |
|---|---|---|
| Price | $21.38 | $17.97 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $32.75 | $27.60 |
| AVG Volume (30 Days) | 1.2M | ★ 1.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.35 | 14.04 |
| EPS | N/A | ★ 0.65 |
| Revenue | ★ $2,730,200,000.00 | $1,288,661,000.00 |
| Revenue This Year | $3.51 | $10.74 |
| Revenue Next Year | $3.86 | $10.93 |
| P/E Ratio | ★ N/A | $27.02 |
| Revenue Growth | N/A | ★ 10.40 |
| 52 Week Low | $19.50 | $16.76 |
| 52 Week High | $41.40 | $28.75 |
| Indicator | QDEL | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 32.93 | 30.26 |
| Support Level | $19.50 | N/A |
| Resistance Level | $30.92 | $23.73 |
| Average True Range (ATR) | 1.69 | 1.00 |
| MACD | -0.12 | -0.25 |
| Stochastic Oscillator | 11.94 | 20.90 |
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.